MADISON – Company working on a prostate cancer vaccine receives funding

Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin.

Madison Vaccines Incorporated said Monday the company has closed on $8 million in financing to move forward with its therapies for prostate cancer.

 
MVI is working on two vaccines to combat prostate cancer, one of which is in Phase 2 clinical trials. The technology was developed in the lab of UW-Madison medical school professor Douglas McNeel.

Read more.

What's New

BizPeople

Sponsored Content

Close the CTA

Summer flash sale!

Limited time offer. New subscribers only.

Unlock all of BizTimes for just $7 / month

Summer flash sale! Unlock all of BizTimes for just $7 / month

Limited time offer. New subscribers only.

Close the CTA

Holiday flash sale!

Limited time offer. New subscribers only.

Subscribe to BizTimes Milwaukee and save 40%

Holiday flash sale! Subscribe to BizTimes and save 40%!

Limited time offer. New subscribers only.